Brochure
17 Aug 2020

SWIFT accelerates evaluation and optimisation of product performance using in vivo clinical data to direct formulation design in real time.

PDF 442 kB

•SWIFT accelerates evaluation and optimisation of product performance using in vivo clinical data to direct formulation design in real time.

•SWIFT studies enable you to make decisions on formulation changes based on emerging clinical data.
 ​
• This integration of formulation development, GMP manufacturing and clinical testing activities can reduce time from initial prototype development to clinical evaluation in as little as 6 months. 

Content provided by our supplier

BDD Pharma

  • GB
  • 2016
    On CPHI since
Company types
Contract Service

Other Content from BDD Pharma ()